Cargando…
Development and validation of an individualized gene expression-based signature to predict overall survival of patients with high-grade serous ovarian carcinoma
BACKGROUND: High-grade serious ovarian carcinoma (HGSOC) is a subtype of ovarian cancer with a different prognosis attributable to genetic heterogeneity. The prognosis of patients with advanced HGSOC requires prediction by genetic markers. This study systematically analyzed gene expression profile d...
Autores principales: | Yuan, Dandan, Zhu, Hong, Wang, Ting, Zhang, Yang, Zheng, Xin, Qu, Yanjun |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10604403/ https://www.ncbi.nlm.nih.gov/pubmed/37884970 http://dx.doi.org/10.1186/s40001-023-01376-0 |
Ejemplares similares
-
A Robust Gene Expression Prognostic Signature for Overall Survival in High-Grade Serous Ovarian Cancer
por: Zhao, Yue, et al.
Publicado: (2019) -
An immune-related gene pairs signature predicts overall survival in serous ovarian carcinoma
por: Zhang, Liuyan, et al.
Publicado: (2019) -
Sphingosine-kinase-1 expression is associated with improved overall survival in high-grade serous ovarian cancer
por: Hanker, L. C., et al.
Publicado: (2021) -
Development and validation of SIRT3-related nomogram predictive of overall survival in patients with serous ovarian cancer
por: Li, Jun, et al.
Publicado: (2019) -
Low-grade Serous Ovarian Carcinoma
por: Ricciardi, Enzo, et al.
Publicado: (2018)